These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30315957)

  • 1. Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany.
    Stecher M; Chaillon A; Eis-Hübinger AM; Lehmann C; Fätkenheuer G; Wasmuth JC; Knops E; Vehreschild JJ; Mehta S; Hoenigl M
    Clin Microbiol Infect; 2019 Feb; 25(2):253.e1-253.e4. PubMed ID: 30315957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hotspots of Transmission Driving the Local Human Immunodeficiency Virus Epidemic in the Cologne-Bonn Region, Germany.
    Stecher M; Hoenigl M; Eis-Hübinger AM; Lehmann C; Fätkenheuer G; Wasmuth JC; Knops E; Vehreschild JJ; Mehta S; Chaillon A
    Clin Infect Dis; 2019 Apr; 68(9):1539-1546. PubMed ID: 30169606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018
    Stecher M; Chaillon A; Stephan C; Knops E; Kohmer N; Lehmann C; Eberle J; Bogner J; Spinner CD; Eis-Hübinger AM; Wasmuth JC; Schäfer G; Behrens G; Mehta SR; Vehreschild JJ; Hoenigl M
    Emerg Infect Dis; 2020 Oct; 26(10):2439-2443. PubMed ID: 32946725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.
    Chaillon A; Nakazawa M; Wertheim JO; Little SJ; Smith DM; Mehta SR; Gianella S
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    Jean Louis F; Domercant JW; Ignacio C; Gianella S; Galbaud G; Leonard M; Smith DM; Chaillon A
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):416-422. PubMed ID: 33136738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
    Gianella S; Delport W; Pacold ME; Young JA; Choi JY; Little SJ; Richman DD; Kosakovsky Pond SL; Smith DM
    J Virol; 2011 Aug; 85(16):8359-67. PubMed ID: 21632754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of HIV-1 transmission clusters and drug-resistant mutations in Denmark, 2004 to 2016.
    Petersen A; Cowan SA; Nielsen J; Fischer TK; Fonager J
    Euro Surveill; 2018 Nov; 23(44):. PubMed ID: 30401010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
    Ross LL; Shortino D; Shaefer MS
    AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
    Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
    AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency of HIV-1 Infection in Iranian Children and Determination of the Transmitted Drug Resistance in Treatment-Naïve Children.
    Jarchi M; Bokharaei-Salim F; Esghaei M; Kiani SJ; Jahanbakhsh F; Monavari SH; Ataei-Pirkooh A; Marjani A; Keyvani H
    Curr HIV Res; 2019; 17(6):397-407. PubMed ID: 31702525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
    Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of HIV-1 molecular transmission networks and drug resistance among men who have sex with men in Tianjin, China (2014-2018).
    Zheng M; Yu M; Cheng S; Zhou N; Ning T; Li L; Zhao F; Zhao X; Zhu J; Jiang G
    Virol J; 2020 Nov; 17(1):169. PubMed ID: 33143744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
    Rojas Sánchez P; Domínguez S; Jiménez De Ory S; Prieto L; Rojo P; Mellado P; Navarro M; Delgado R; Ramos JT; Holguín Á;
    Pediatr Infect Dis J; 2018 Mar; 37(3):e48-e57. PubMed ID: 28991889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A
    J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City.
    Gagliardo C; Brozovich A; Birnbaum J; Radix A; Foca M; Nelson J; Saiman L; Yin M; Carras-Terzian E; West E; Neu N
    Clin Infect Dis; 2014 Mar; 58(6):865-72. PubMed ID: 24429431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
    Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
    PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
    Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
    AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.